B+
Bull case
25%
Probability
Target price
$9.00
+65.7% vs current
NUS
Nu Skin EnterprisesCNYSE / Household & Personal Products
Last Price
At close
2026-06-11
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$7.00
+28.9% vs current
B-
Bear case
25%
Probability
Target price
$5.50
+1.3% vs current
AI sentiment snapshot
Latest data as of 2026-04-15
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+77.6
Score
AI commentary
Primary-source support is real, but the thesis still looks like a cautious monitoring setup rather than a high-conviction long. The best near-term upside hook is whether Prysm iO can create a mix and engagement lift, yet that remains unproven until reported results. Balance-sheet risk is less acute after the March refinancing, though not gone. Net: neutral to slightly cautious into the May 7, 2026 earnings event.
RankAlpha Sentiment Codex - 2026-04-15
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-07eventMay 7, 2026 Q1 print is the next hard read-throughHigh impact
Nu Skin said on April 13, 2026 it will release first-quarter 2026 results on May 7 after market close and discuss recent results plus upcoming business initiatives, making that report the next clean checkpoint for demand, margin and rollout commentary [#PR-2026-04-13].
2026-06-30catalystRefinanced credit facility reduces near-term maturity pressure but keeps leverage in focusMedium impact
The March 27, 2026 credit amendment provides a $175 million term loan and $75 million revolver, with proceeds used to repay the prior facility; that removes one overhang, but the new agreement still carries leverage and interest-coverage covenants that leave execution room limited if operating results soften [#8-K-2026-03-27][#10-Q-2025-11-07].
2026-09-30catalystPrysm iO launch could improve mix, but adoption proof is still pendingHigh impact
The company launched Prysm iO for general consumer availability in the U.S. on April 2, 2026, with other markets planned in coming months; if device uptake and supplement attach improve, mix could benefit, but monetization remains early and needs proof in reported results [#PR-2026-04-02][#10-K-2026-02-13].
Recommendation
N/A
No formal recommendation provided.
As of 2026-04-15 • Updated nightlySource: Internal modelMethodology